The contribution of metformin to glycaemic control in patients with Type 2 diabetes mellitus receiving combination therapy with insulin.
Tong, P C
The contribution of metformin to glycaemic control in patients with Type 2 diabetes mellitus receiving combination therapy with insulin. [electronic resource] - Diabetes research and clinical practice Aug 2002 - 93-8 p. digital
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0168-8227
10.1016/s0168-8227(02)00022-0 doi
Blood Glucose--metabolism
Body Mass Index
Diabetes Mellitus, Type 2--blood
Drug Therapy, Combination
Fasting
Female
Humans
Hypoglycemic Agents--therapeutic use
Insulin, Isophane--therapeutic use
Male
Metformin--therapeutic use
Middle Aged
Postprandial Period
Sulfonylurea Compounds--therapeutic use
The contribution of metformin to glycaemic control in patients with Type 2 diabetes mellitus receiving combination therapy with insulin. [electronic resource] - Diabetes research and clinical practice Aug 2002 - 93-8 p. digital
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0168-8227
10.1016/s0168-8227(02)00022-0 doi
Blood Glucose--metabolism
Body Mass Index
Diabetes Mellitus, Type 2--blood
Drug Therapy, Combination
Fasting
Female
Humans
Hypoglycemic Agents--therapeutic use
Insulin, Isophane--therapeutic use
Male
Metformin--therapeutic use
Middle Aged
Postprandial Period
Sulfonylurea Compounds--therapeutic use